La voie de signalisation PI3K-AKT-mTOR : description, développement thérapeutique, résistances, marqueurs prédictifs/pronostiques et applications thérapeutiques en cancérologie

Published 2016 View Full Article

Authors

Keywords

mTOR inhibitor, PI3K-AKT-mTOR, Everolimus, Temsirolimus, Resistance, Biomarker

Journal

BULLETIN DU CANCER

Volume 103, Issue 1, Pages 18-29

Publisher

Elsevier BV

Online

2015-11-13

DOI

10.1016/j.bulcan.2015.09.011

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started